Inventiva (IVA) Operating Expenses (2019 - 2021)
Inventiva's (IVA) quarterly Operating Expenses came in at -$18.0 million in Q2 2021, down 95.75% year-on-year from -$423.3 million in Q2 2020, and down 564.09% quarter-over-quarter from -$2.7 million in Q1 2021.
Inventiva (IVA) Operating Expenses (2019 - 2021) Analysis & Trends
Inventiva's Operating Expenses history runs 3 years deep, the most recent figure standing at -$18.0 million for Q2 2021.
- On a quarterly basis, Operating Expenses fell 95.75% year-over-year to -$18.0 million in Q2 2021; TTM through Sep 2022 was -$18.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $157.1 million, up 37.74% from the prior year.
- Operating Expenses retreated to -$18.0 million in Q2 2021 per IVA's latest filing, from -$2.7 million in the prior quarter.
- Across five years, Operating Expenses topped out at -$14351.2 in Q1 2020 and bottomed at -$44.1 million in Q4 2019.
- The 3-year median for Operating Expenses is -$13.6 million (2020), against an average of -$18.7 million.
- Across the five-year window, Operating Expenses climbed 12.98% in 2020 and plunged 18794.71% in 2021, its largest moves.
- Year by year, Operating Expenses stood at -$44.1 million in 2019, then climbed by 12.98% to -$38.4 million in 2020, then jumped by 53.12% to -$18.0 million in 2021.
- Per Business Quant, the three latest IVA Operating Expenses figures stand at -$18.0 million (Q2 2021), -$2.7 million (Q1 2021), and -$38.4 million (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -18.01 Mn |
| Mar 31, 2021 | -2.71 Mn |
| Dec 31, 2020 | -38.41 Mn |
| Jun 30, 2020 | -9.20 Mn |
| Mar 31, 2020 | -14,351.21 |
| Dec 31, 2019 | -44.14 Mn |